A Surprising Discovery: Financial Incentives and Blood Pressure Control
In a recent study presented at the American Heart Association's Scientific Sessions 2025, researchers explored an intriguing approach to improving medication adherence among individuals with high blood pressure. The findings, however, revealed a twist that challenges conventional wisdom.
The Study Setup
The Behavioral Economics Trial To Enhance Regulation of Blood Pressure (BETTER-BP) study focused on 400 adults with high blood pressure from three community health clinics in New York City. These clinics primarily serve individuals with Medicaid coverage or no insurance, a population known to face challenges with medication adherence and blood pressure control.
Participants were randomly divided into two groups: one group eligible for cash rewards for taking their medication, and a control group without this incentive. All participants admitted to not taking their blood pressure medication as prescribed before the study.
Monitoring and Results
Researchers used electronic pill bottles to track medication use, a more reliable method than self-reporting. The average systolic blood pressure among participants was 139 mm Hg at the study's start, higher than the normal range of less than 120 mm Hg.
The key findings were:
- Financial incentives doubled consistent medication use, with 71% of the rewards group taking their medication regularly compared to 34% in the control group.
- Despite this increased adherence, both groups experienced similar reductions in systolic blood pressure at six months.
- After the rewards program ended, participants reverted to their previous inconsistent medication habits.
The Controversy
Here's where it gets interesting: financial incentives clearly motivated participants to take their medication more regularly, but this behavior change didn't lead to significantly better blood pressure control. This raises questions about the effectiveness of such incentives and the complexity of long-term behavior modification.
John Dodson, M.D., the study's principal investigator, expressed surprise at this outcome. He suggested that the lack of change could be due to participants opening bottles without taking the medication, or other untracked factors like medication type or lifestyle behaviors.
Limitations and Future Directions
The study had limitations, including the electronic pill bottles' inability to confirm medication ingestion, the monitoring of only one blood pressure medication per participant, and the use of standardized office blood pressure measurements rather than frequent home monitoring.
Despite these limitations, the study highlights the need for a deeper understanding of the factors influencing medication adherence and long-term behavior changes. Further research is required to explore these unknowns and develop effective strategies to improve blood pressure control and reduce cardiovascular risks.
Takeaway
Financial incentives can indeed influence behavior, but the impact on health outcomes is less clear. This study underscores the complexity of behavior change and the need for comprehensive strategies that address multiple factors influencing medication adherence and long-term health.
What are your thoughts on this study's findings? Do you think financial incentives are an effective tool for improving health behaviors, or are there other approaches we should prioritize? We'd love to hear your opinions in the comments!
